Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Short-Term Debt issuances (2023 - 2025)

SRx Health Solutions (SRXH) has disclosed Short-Term Debt issuances for 5 consecutive years, with $859000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Short-Term Debt issuances fell 66.47% year-over-year to $859000.0, compared with a TTM value of $4.0 million through Jun 2025, up 59.06%, and an annual FY2023 reading of $7.8 million, up 1798.55% over the prior year.
  • Short-Term Debt issuances was $859000.0 for Q2 2025 at SRx Health Solutions, up from $653000.0 in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $2.6 million in Q2 2024 and bottomed at -$41000.0 in Q1 2023.
  • Average Short-Term Debt issuances over 3 years is $1.0 million, with a median of $756000.0 recorded in 2024.
  • Peak annual rise in Short-Term Debt issuances hit 66.47% in 2025, while the deepest fall reached 66.47% in 2025.
  • Year by year, Short-Term Debt issuances stood at -$41000.0 in 2023, then skyrocketed by 1692.68% to $653000.0 in 2024, then surged by 31.55% to $859000.0 in 2025.
  • Business Quant data shows Short-Term Debt issuances for SRXH at $859000.0 in Q2 2025, $653000.0 in Q4 2024, and $2.6 million in Q2 2024.